Uncategorized Archives - Page 77 of 87 - PsychedelicNewsWire (PNW)

FridayMar 01, 2019 11:13 am

Marijuana Company of America Inc.’s (MCOA) High-Yielding Hemp Projects Blossom as ‘Green Industry’ Set to Thrive in 2019

Global hemp retail sales totaled $3.7 billion in 2018, on track to reach $5.7 billion by 2020 2018 Farm Bill legalizing hemp, CBD-based products, now allows farmers to plant industrial hemp nationwide Cultivation of hemp at Scio, Oregon, project site to begin in early 2019 for an extended growing season MCOA’s wholly owned subsidiary, hempSMART, brings high quality, branded CBD-based products to consumers through an affiliate marketing program Market opportunities for the hemp-based cannabidiol (“CBD”) product industry in the U.S. are many and growing now that hemp is legally protected following passage of the 2018 Farm Bill in December. Innovative…

ThursdayFeb 14, 2019 1:53 pm

Marijuana Company of America Inc. (MCOA) Promotes Brand During Super Bowl and Hollywood Events

February events have and will continue to provide the company with opportunities to increase its recognition amid Super Bowl and pre-Academy Awards gatherings Marijuana Company of America Inc. upgraded its market tier to the OTCQB Venture Exchange in December The company is aggressively pursuing a strategy of building a following for its hemp products by marketing to celebrities and pro athletes Amid the rise of the cannabis industry and the high degree of attention that consumers and investors alike are paying to the varied applications of the plant and its derivatives, Marijuana Company of America Inc. (OTCQB: MCOA) is raising…

MondayFeb 11, 2019 11:21 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Creates Unique Opportunity in Global Cannabis Industry

Big corporations are investing in the cannabis industry Major tobacco company provides financing for LXRP LXRP boasts revenue streams within the nicotine industry and opportunity in other sectors Lexaria is a unique company doing business on its own terms The cannabis industry is experiencing impressive growth thanks to both legal and social changes worldwide, and big corporations are stepping up to invest. In a new Audio Press Release (“APR”), PsychedelicNewsAudio praised Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (http://cnw.fm/Ap2N5) for building a large funding deal on its own terms. The APR, ‘Outside Investment, New Technology Support Growing Cannabis Industry’, highlighted Lexaria’s ability…

ThursdayJan 24, 2019 11:37 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Acquires a $12 Million Investor

Lexaria Nicotine LLC partners with one of the world’s largest tobacco companies Opportunity to change nicotine delivery and improve the lives of millions Retains ownership of DehydraTECH while licensing the technology out to multiple industries Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) recently announced that its wholly owned subsidiary, Lexaria Nicotine LLC, has partnered with one of the world’s largest tobacco companies to fund the research and development of Lexaria’s patented DehydraTECH (http://cnw.fm/w86Vf). The partnership may potentially commercialize this cutting-edge technology for oral nicotine delivery. Chris Bunka, CEO of Lexaria Bioscience, is excited about the opportunity to work with a world-class…

FridayJan 11, 2019 11:10 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Discusses Company Initiatives at O’Cannabiz 2018

Lexaria Bioscience has its innovative DehydraTECH drug delivery platform The company’s DehydraTECH technology is complementary to other R&D being done on cannabinoids Lexaria recently attended O’Cannabiz 2018 in Vancouver A biotech company, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) offers a unique platform that makes it possible to deliver bioactive substances through oral ingestion. Its DehydraTECH technology accomplishes this without the need for unhealthy inhalational dosing. DehydraTECH uses only GRAS (Generally Recognized as Safe) ingredients and increases bio-absorption by five to 10 times. Based in Kelowna, British Columbia, Lexaria Bioscience is the only company globally with patents issued for the…

TuesdayDec 04, 2018 11:27 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Submits Application for Research License to Health Canada

Lexaria has developed its DehydraTECH technology The company also has four new subsidiaries Lexaria recently submitted its application to Health Canada for a research license Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a research-driven company that has developed and out-licenses its DehydraTECH technology – a drug delivery platform. It is the only company globally with a patent issued for oral delivery of all cannabinoids. The company’s technology facilitates the delivery of bioactive substances via oral ingestion without the need for inhalational dosing or co-administration with sugars or sweeteners. Lexaria Bioscience is headquartered in Kelowna, British Columbia. Lexaria has four…

TuesdayDec 04, 2018 11:06 am

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Keeps its Vision High as Cannabis Prospects Continue to Germinate through Political Changes

U.S. midterm elections signal growing fortunes for cannabis industries with pro-cannabis voting, ouster of anti-cannabis attorney general Phivida among cannabis industry companies that enjoy stock boost in immediate wake of elections Phivida enthused by new FDA and DEA acceptance of natural cannabis in pharmaceuticals, which opens prospects for non-FDA administered products as well Company announces appointment of new senior vice president of distribution to optimize placement of its products in functional food and beverage markets A rolling groundswell of progressive developments in the cannabis use seascape, driven by winds of change in North America’s political arenas, is underscoring the optimism…

WednesdayNov 28, 2018 12:06 pm

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Mobile Hemp Oil Supplement Powder Packet, ChrgD+, Utilizes DehydraTECH Technology

LXRP partners with Cultivating Wellness Inc. (“CW”) to formulate the ChrgD+ premium brand and will now focus on selling it to CW’s national distribution network of retailers The two-gram powder packets are water soluble and can be added to any hot/cold beverage; they are a ready-mix hemp oil supplement that can be added to drinks, such as coffee DehydraTECH has already received multiple patents, and LXRP is a drug delivery platform innovator; the introduction is seen as a first step in the relationship between the companies Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) introduction of ChrgD+ powder packets, which can…

WednesdayNov 14, 2018 12:11 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Grows Stronger with Patents and Third-Party Partners

Improving the quality, taste and effectiveness of cannabis products with DehydraTECH Recently granted two new U.S. patents, with over 50 additional patent applications filed worldwide Applications span a wide range of products as the company out-licenses IP to third-party partners through a royalty model Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is using its DehydraTECH to increase the quality, taste and effectiveness of cannabis products. Lexaria’s revolutionary drug delivery platform is disrupting the way cannabidiol enters the bloodstream. Rather than relying on the traditional methods of inhalation, which has harmful lasting impact on a person’s health, DehydraTECH allows for a…

ThursdayNov 08, 2018 9:45 am

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Private Placement Raises Gross Proceeds of $1.5M; Funds Allocated for Canadian Lab, R&D

Increased size of non-brokered private placement raises gross proceeds of $1,515,440, to be used to fund construction of new Canadian lab, LXRP's R&D and general corporate purposes LXRP has received two new U.S. patents related to cannabinoid infused beverage compositions using DehydraTECH; the company is a drug delivery innovator The company has expanded its IP portfolio, giving it a total of 10 patents in its first family in the U.S. and Australia; it has 50 patent applications globally and out-licenses its technology Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has raised, in a non-brokered private placement, a total of $1,515,440.…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Uncategorized